Aerie Pharma Balance Sheet - Quarterly (NASDAQ:AERI)

Add to My Stocks
$56.55 $0.4 (0.71%) AERI stock closing price Sep 18, 2018 (Closing)

The Aerie Pharma balance sheet is a snapshot of the company's financial health at a given point of time, whereas the other two financial statements are for a particular accounting period. As in our Aerie Pharma stock analysis, analyzing a company also involves looking at the company's assets and liabilities as given in its balance sheet, which can be used to measure financial performance. Quarterly results announcements include the release of all three financial statements, of which the balance sheet is one. Apart from analyzing Aerie Pharma revenue Aerie Pharma operating cash flow, one needs to check balance sheet items like cash, fixed assets and debt. The Aerie Pharma balance sheet for 2018 Q2 shows cash on hand of $270.65M. The company has a debt to equity ratio of .

View and download Aerie Pharma quarterly results to get the balance sheet details for the latest 40 quarters data.
show more
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Cash270.65M249.5M197.56M194.07M242.65M139.53M197.94M211.93M58.51M74.26M
Marketable Securities15.46M84.47M52.08M87.25M65.26M68.33M35.71M41.69M48.51M45.02M
Receivables1.13M---------
Inventory5.75M1.06M--------
Raw Materials----------
Work In Progress----------
Finished Goods----------
Notes Receivable----------
Other Current Assets2.5M6.11M4.48M2.06M2.05M2.35M4.02M2.91M1.17M1.4M
Total Current Assets
295.48M341.15M254.14M283.39M309.97M210.21M237.69M256.54M108.2M120.69M
Property Plant & Equipment--34.94M---10.1M---
Accumulated Depreciation--3M---2.24M---
Net Property Plant & Equipment
54.88M47.81M31.93M19.24M14.39M12.53M7.85M4.6M3.84M3.99M
Investment & Advances-------1.97M5.1M11.48M
Other Non-Current Assets----------
Deferred Charges----------
Intangibles----------
Deposits & Other Assets2.6M2.07M4.2M2.65M2.61M2.66M2.7M2.79M2.97M3.03M
Total Assets
352.96M391.04M290.27M306.2M326.98M225.4M248.25M265.91M120.13M139.2M
Notes Payable------2.33M---
Accounts Payable8.76M6.06M6.24M18.04M13.26M13.02M18.82M13.54M13.59M15.5M
Current Portion Long-Term Debt----------
Current Portion Capital Leases----------
Accrued Expenses20.02M19.07M18.93M-------
Income Taxes Payable----------
Other Current Liabilities----------
Total Current Liabilities
28.77M25.13M25.18M18.59M13.81M13.56M19.37M14.09M14.14M16.04M
Mortgages----------
Deferred Taxes/Income----------
Convertible Debt124M123.92M123.84M123.76M123.69M123.61M123.53M123.46M123.38M123.31M
Long-Term Debt----------
Non-Current Capital Leases----------
Other Long-Term Liabilities5.31M5.71M5.64M4.56M4.44M4.11M----
Total Liabilities
158.08M154.77M154.67M146.93M141.94M141.29M142.91M137.56M137.53M139.35M
Minority Interest----------
Preferred Stock----------
Common Stock Net----------
Capital Surplus754.44M740.95M597.31M562.54M555.93M426.59M422M415.63M246.07M240.15M
Retained Earnings-559.59M-504.56M-461.72M-403.21M-370.84M-342.41M-316.62M-287.3M-263.48M-240.26M
Treasury Stock----------
Other Liabilities-0.01M-0.15M-0.02M-0.09M-0.08M-0.1M-0.06M-0.01M-0.01M-0.06M
Shareholders Equity194.88M236.27M135.59M159.26M185.04M84.11M105.34M128.35M-17.4M-0.15M
Total Liabilities & Shareholders Equity352.96M391.04M290.27M306.2M326.98M225.4M248.25M265.91M120.13M139.2M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

The latest Aerie Pharma stock price, and Aerie Pharma historical stock prices show the stock price movement over time, and the Aerie Pharma PE ratio chart displays the PE ratio movement. Apart from stock price, one should also look at balance sheet items which mainly comprise of the following:

  • Assets: An asset is a resource that a corporation like Aerie Pharma owns and has monetary significance. AERI assets decreased from $391.04M in 2018 Q1 to $352.96M in 2018 Q2. Assets can be of two types: fixed assets like real estate, plant and machinery; and current assets which includes cash, accounts receivable etc. Tech stocks typically don't have too many assets.
  • Liabilities: The total liabilities of Aerie Pharma for the quarter 2018 Q2 total to $158.08M. Liabilities for a company like Aerie Pharma include bank loans, services which have been availed for which a settlement in the form of cash/ asset transfer needs to be done in future etc. A firm takes on such obligations to grow its business which in turn will generate future economic benefits for its business.

Aerie Pharma Balance Sheet - Key Ratios